Indication
Tetanus Immunization
1 clinical trial
1 product
Clinical trial
An Observer-blind, Randomized, Active-controlled, Multi-centric Phase III Study to Assess Immunogenicity and Safety of Hexavalent (DTwP-Hepatitis B-IPV-Hib) Vaccine Containing Reduced Dose IPV in Comparison With HEXASIIL®Status: Recruiting, Estimated PCD: 2025-08-31
Product
Hexavalent Vaccine